US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 2.120
  • -0.190-8.23%
Close Mar 28 16:00 ET
  • 2.040
  • -0.080-3.77%
Post 20:01 ET
7.20MMarket Cap-0.09P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
64.20%2.27M
-2.66%366K
-37.24%214K
141.58%1.1M
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
457K
206K
Operating revenue
64.20%2.27M
-2.66%366K
-37.24%214K
141.58%1.1M
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
--457K
--206K
Cost of revenue
70.08%2.14M
16.53%832K
128.52%1.17M
138.46%62K
788.89%80K
6,200.00%1.26M
7,833.33%714K
4,554.55%512K
26K
9K
Gross profit
2.50%123K
-37.87%-466K
-459.06%-956K
141.76%1.04M
154.82%502K
-66.20%120K
-247.60%-338K
-235.71%-171K
431K
197K
Operating expense
-61.29%64.93M
-48.84%10M
-70.92%12.78M
-66.92%17.48M
-52.01%24.67M
4.84%167.74M
-63.22%19.54M
12.39%43.96M
45.63%52.85M
63.26%51.4M
Selling and administrative expenses
-58.65%34.49M
-57.37%4.09M
-68.44%7.68M
-63.47%9.45M
-43.78%13.26M
21.31%83.41M
-53.53%9.6M
42.75%24.34M
40.75%25.87M
82.61%23.6M
-Selling and marketing expense
----
----
-76.92%1.06M
-95.59%305K
-66.44%872K
6.93%19.9M
-85.26%1.43M
67.90%4.6M
9.46%6.91M
281.50%2.6M
-General and administrative expense
-45.69%34.49M
-49.94%4.09M
-66.47%6.62M
-51.77%9.15M
-40.98%12.39M
26.64%63.51M
-25.62%8.18M
37.94%19.75M
57.11%18.96M
71.54%21M
Research and development costs
-63.91%30.44M
-40.60%5.9M
-74.00%5.1M
-70.22%8.03M
-58.99%11.4M
-7.58%84.33M
-69.40%9.93M
-11.07%19.62M
50.64%26.97M
49.79%27.8M
Operating profit
61.34%-64.8M
47.37%-10.46M
68.87%-13.74M
68.63%-16.44M
52.80%-24.16M
-4.99%-167.62M
62.42%-19.88M
-13.19%-44.13M
-44.44%-52.41M
-62.64%-51.2M
Net non-operating interest income expense
-63.43%-12.53M
-47.21%-3.66M
-45.33%-3.17M
-84.92%-3.03M
-96.75%-2.66M
-34.83%-7.67M
-73.57%-2.49M
24.09%-2.18M
-18.52%-1.64M
-17,000.00%-1.35M
Non-operating interest income
-53.94%2.6M
-61.10%368K
-42.32%616K
-58.61%671K
-53.00%947K
123.46%5.65M
-36.34%946K
29.77%1.07M
694.61%1.62M
13,333.33%2.02M
Non-operating interest expense
13.63%15.13M
17.38%4.03M
16.54%3.79M
13.53%3.7M
7.13%3.61M
62.11%13.31M
17.64%3.44M
-12.11%3.25M
105.49%3.26M
48,000.00%3.37M
Other net income (expense)
570.47%17.73M
2,924.07%3.27M
178.31%3.26M
1,980.07%11.17M
113.01%32K
-782.67%-3.77M
122.50%108K
-6,822.58%-4.17M
537K
-246K
Special income (charges)
41.36%-2.44M
---32K
62.70%-1.55M
---856K
----
---4.16M
--0
---4.16M
--0
----
-Less：Restructuring and merger&acquisition
-41.36%2.44M
--32K
-62.70%1.55M
--856K
----
--4.16M
--0
--4.16M
--0
----
Other non- operating income (expenses)
5,020.05%20.17M
2,953.70%3.3M
96,440.00%4.82M
2,139.48%12.03M
113.01%32K
192.27%394K
122.50%108K
-108.06%-5K
--537K
---246K
Income before tax
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
Income tax
Net income
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
Net income continuous Operations
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
Minority interest income
Net income attributable to the parent company
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
Basic earnings per share
76.11%-23.51
70.64%-3.57
81.40%-5.12
88.52%-3.36
52.72%-13.92
-3.89%-98.4
61.03%-12.16
-15.44%-27.52
-35.56%-29.28
-64.29%-29.44
Diluted earnings per share
76.11%-23.51
70.64%-3.57
81.40%-5.12
88.52%-3.36
52.72%-13.92
-3.89%-98.4
61.03%-12.16
-15.44%-27.52
-35.56%-29.28
-64.29%-29.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 64.20%2.27M-2.66%366K-37.24%214K141.58%1.1M182.52%582K268.00%1.38M57.98%376K148.91%341K457K206K
Operating revenue 64.20%2.27M-2.66%366K-37.24%214K141.58%1.1M182.52%582K268.00%1.38M57.98%376K148.91%341K--457K--206K
Cost of revenue 70.08%2.14M16.53%832K128.52%1.17M138.46%62K788.89%80K6,200.00%1.26M7,833.33%714K4,554.55%512K26K9K
Gross profit 2.50%123K-37.87%-466K-459.06%-956K141.76%1.04M154.82%502K-66.20%120K-247.60%-338K-235.71%-171K431K197K
Operating expense -61.29%64.93M-48.84%10M-70.92%12.78M-66.92%17.48M-52.01%24.67M4.84%167.74M-63.22%19.54M12.39%43.96M45.63%52.85M63.26%51.4M
Selling and administrative expenses -58.65%34.49M-57.37%4.09M-68.44%7.68M-63.47%9.45M-43.78%13.26M21.31%83.41M-53.53%9.6M42.75%24.34M40.75%25.87M82.61%23.6M
-Selling and marketing expense ---------76.92%1.06M-95.59%305K-66.44%872K6.93%19.9M-85.26%1.43M67.90%4.6M9.46%6.91M281.50%2.6M
-General and administrative expense -45.69%34.49M-49.94%4.09M-66.47%6.62M-51.77%9.15M-40.98%12.39M26.64%63.51M-25.62%8.18M37.94%19.75M57.11%18.96M71.54%21M
Research and development costs -63.91%30.44M-40.60%5.9M-74.00%5.1M-70.22%8.03M-58.99%11.4M-7.58%84.33M-69.40%9.93M-11.07%19.62M50.64%26.97M49.79%27.8M
Operating profit 61.34%-64.8M47.37%-10.46M68.87%-13.74M68.63%-16.44M52.80%-24.16M-4.99%-167.62M62.42%-19.88M-13.19%-44.13M-44.44%-52.41M-62.64%-51.2M
Net non-operating interest income expense -63.43%-12.53M-47.21%-3.66M-45.33%-3.17M-84.92%-3.03M-96.75%-2.66M-34.83%-7.67M-73.57%-2.49M24.09%-2.18M-18.52%-1.64M-17,000.00%-1.35M
Non-operating interest income -53.94%2.6M-61.10%368K-42.32%616K-58.61%671K-53.00%947K123.46%5.65M-36.34%946K29.77%1.07M694.61%1.62M13,333.33%2.02M
Non-operating interest expense 13.63%15.13M17.38%4.03M16.54%3.79M13.53%3.7M7.13%3.61M62.11%13.31M17.64%3.44M-12.11%3.25M105.49%3.26M48,000.00%3.37M
Other net income (expense) 570.47%17.73M2,924.07%3.27M178.31%3.26M1,980.07%11.17M113.01%32K-782.67%-3.77M122.50%108K-6,822.58%-4.17M537K-246K
Special income (charges) 41.36%-2.44M---32K62.70%-1.55M---856K-------4.16M--0---4.16M--0----
-Less：Restructuring and merger&acquisition -41.36%2.44M--32K-62.70%1.55M--856K------4.16M--0--4.16M--0----
Other non- operating income (expenses) 5,020.05%20.17M2,953.70%3.3M96,440.00%4.82M2,139.48%12.03M113.01%32K192.27%394K122.50%108K-108.06%-5K--537K---246K
Income before tax 66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M
Income tax
Net income 66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M
Net income continuous Operations 66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M
Minority interest income
Net income attributable to the parent company 66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M
Basic earnings per share 76.11%-23.5170.64%-3.5781.40%-5.1288.52%-3.3652.72%-13.92-3.89%-98.461.03%-12.16-15.44%-27.52-35.56%-29.28-64.29%-29.44
Diluted earnings per share 76.11%-23.5170.64%-3.5781.40%-5.1288.52%-3.3652.72%-13.92-3.89%-98.461.03%-12.16-15.44%-27.52-35.56%-29.28-64.29%-29.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cisco
CSCO
-0.88%
NVIDIA
NVDA
-1.58%
Broadcom
AVGO
-1.67%
Taiwan Semiconductor
TSM
-1.78%
ASML Holding
ASML
-2.32%

Unlock the Full List